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Objectives A mixture model of crown–rump length (CRL)-dependent and CRL-independent nuchal
translucency (NT) measurements has been proposed for antenatal screening for Down’s syndrome.
We here compare the efﬁcacy of the mixture model method with the standard method, which uses
NT multiple of the median (MoM) values in a single distribution.
Settings A routine antenatal screening programme for Down’s syndrome comprising 104 affected
and 22,284 unaffected pregnancies.
Methods The ability of NT to distinguish between affected and unaffected pregnancies was
compared using the mixture model method and the standard MoM method by using published
distribution parameters for the mixture model of NT and parameters derived from these for the
standard MoM method. The accuracy of the two methods was compared for NT and maternal age
by comparing the median estimated risk with the prevalence of Down’s syndrome in different
categories of estimated risk.
Results Using NTalone observed estimates of discrimination using the two methods are similar; at a
70% detection rate the false-positive rates were 12% using the mixture model method and 10% using
the MoM method. Risk estimation was marginally (but not statistically signiﬁcantly) more accurate
using the standard MoM method.
Conclusions The mixture model method offers no advantage over the standard MoM method in
antenatal screening for Down’s syndrome, is more complicated and less generalizable to other
data-sets. The standard MoM method remains the method of choice.
INTRODUCTION
I
t has been proposed that nuchal translucency (NT)
measurements (in mm) in antenatal screening for
Down’s syndrome be ﬁtted to two distributions in
affected pregnancies and two distributions in unaffected
pregnancies at each crown–rump length (CRL) measure-
ment – a mixture model.
1 It was suggested that this model
better describes NT measurements than the standard
method of using a single distribution of NT for affected preg-
nancies and a single distribution for unaffected pregnancies
at each day of gestation (with NT expressed as multiple of
the median [MoM] values and gestational age estimated
from CRL) but this has not been shown. The mixture
model method assumes that in the majority of unaffected
pregnancies NT increases with increasing CRL, while in the
remainder NT is constant, and conversely in the majority
of affected pregnancies NT is constant with increasing CRL,
while in the remainder NT increases. The mixture model
method involves estimating a relatively large number of
NT distribution parameters (means, standard deviations
and proportions that are CRL-dependent and CRL-
independent) compared with the standard MoM method.
This is described in Appendix A.
A concern with the use of a mixture model to describe the
distribution of NT measurements is that the model may be
too tailored to the data-set from which it was derived and
may not be generalizable to other data-sets. This concern
and the lack of comparison with the standard MoM
method in the report proposing its use
1 prompted us to
perform a quantitative comparison of the two methods
using an independent data-set to determine whether the
mixture model offers an improvement in antenatal screen-
ing for Down’s syndrome.
METHODS
We compared the proposed mixture model method with the
standard MoM method using data on the 104 Down’s syn-
drome and the 22,284 unaffected pregnancies screened
at the Wolfson Institute of Preventive Medicine with CRL
measurements between 45 and 84 mm (between 11 þ 0
and 13 þ 6 weeks gestation discussed in our accompanying
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2 two affected and 356
unaffected pregnancies with CRL measurements less than
45 mm were excluded because no parameters were speciﬁed
in the proposed mixture model for CRL measurements less
than 45 mm.
1
In the proposed mixture model among both Down’s syn-
drome and unaffected pregnancies, NT is dependent on CRL
in some pregnancies and independent of CRL in others. A
mixture of a CRL-dependent Gaussian distribution and a
CRL-independent Gaussian distribution is used to describe
NT measurements in both affected and unaffected pregnan-
cies at each CRL measurement.
Unaffected pregnancies
(1) In the majorityof unaffected pregnancies NT depends on
CRL, with a log-quadratic relationship used to describe
the change in NT with increasing CRL. The standard
deviation of NT is assumed independent of CRL. This
generates a Gaussian distribution at each CRL, with a
different mean but the same standard deviation;
(2) In the remainder of unaffected pregnancies NT is inde-
pendent of CRL, so the same Gaussian distribution is
used across the range of CRL.
Down’ssyndromepregnancies
(1) In the majority of affected pregnancies NT is indepen-
dent of CRL, so the same Gaussian distribution is
used across the range of CRL;
(2) In the remainder of affected pregnancies NT is depen-
dent on CRL and the distributions at each CRL are
assumed to be the same as the CRL-dependent distri-
butions in unaffected pregnancies.
Ninety-fourpercentofDown’ssyndromepregnanciesfollowthe
CRL-independent distribution. In unaffected pregnancies the
proportion decreases with increasing CRL, from about 12% at
a CRL of 45 mm to 3% at a CRL of 84 mm. The 10 parameters
of a mixture model (ﬁve for affected – 2 means, 2 standard
deviations and the proportion for one or other distribution,
and 5 for unaffected) are estimated simultaneously, which
can be done in various ways. One method selects different
combinations of the parameters for affected pregnancies and
‘converges’ on the combination that ﬁts the data most
closely. The same is repeated for unaffected pregnancies.
The parameters (means and standard deviations) for
the single distributions of NT MoM values in affected and
unaffected pregnancies at 11, 12 and 13 completed weeks
were derived from the mixture model parameters for
CRL measurements that correspond to these gestational
ages (49, 62 and 76 mm, respectively
3) using integration
methods (see Appendix B).
Screening performance of the two methods were com-
pared, by applying the two sets of parameters (mixture
model and MoM) to data on the 104 Down’s syndrome
and the 22,284 unaffected pregnancies. For each pregnancy,
the likelihood ratio for each method was calculated and
detection rates for speciﬁed false-positive rates and false-
positive rates for speciﬁed detection rates calculated. The
accuracy of risk estimation of the two methods using NT
and maternal age was compared using a validation method
previously described.
4 Categories of risk were deﬁned by
quintiles of risk in affected pregnancies (so that there are
approximately equal numbers of affected pregnancies in
each category) and the prevalence of Down’s syndrome in
each category is tabulated with the median estimated risk
in each category.
RESULTS
Figure 1 shows the relative frequency distributions of NT in
Down’s syndrome and unaffected pregnancies at 11, 12 and
13 completed weeks’ gestation together with truncation
limits using the mixture model method and the standard
MoM method (the parameters [means and standard devi-
ations] of the mixture model method distributions and stan-
dard MoM method distributions are given in Appendix B,
Table B1). With the mixture model method the distribution
in affected pregnancies remains approximately stationary
from week to week while the distribution in unaffected preg-
nancies moves to the right as gestation increases. With the
standard MoM method the distribution in affected pregnan-
cies moves to the left with increasing gestation while the dis-
tribution in unaffected pregnancies remains stationary.
Figure 1 shows that the mixture distributions are similar
to the MoM distributions, i.e. since the proportion of
unaffected pregnancies that have CRL-independent NT
and the proportion of affected pregnancies that have
CRL-dependent NT are low the mixture distributions closely
resemble the Gaussian distributions of NT MoM values.
Table 1 shows the screening performance of using NT
alone with the mixture model method and with the stan-
dard MoM method, using an independent data-set, i.e. a
data-set not used to derive the distribution parameters.
There is a marginal improvement in screening performance
using the standard MoM method.
Table 2 compares the accuracy of risk estimation of the
two methods using NT and maternal age. The MoM
method provides the more accurate risk estimates. The esti-
mated risk using the mixture model approach is lower than
the prevalence in each category but this bias is not evident
using the standard MoM method. However, the differences
are small and could be due to chance. The MoM method
pulls risk estimation further apart than the mixture model
method; the median risk was one in 26 in Down’s syndrome
pregnancies and one in 2114 in unaffected pregnancies
using the MoM method, compared with one in 53 and
one in 1858, respectively, using the mixture model
approach, supporting the conclusions seen in Table 2.
Single distribution NT MoM parameters derived from the
mixture model NT (mm) parameters are unlikely to be
exactly the same as those derived directly from the raw
data because methods of estimation are usually used that
avoid the inﬂuence of outliers. For this reason we performed
a sensitivity analysis, comparing screening performance by
increasing or decreasing the derived median MoM in
Down’s syndrome pregnancies by 20%, and by increasing
or decreasing the standard deviations in Down’s syndrome
and unaffected pregnancies by 20%. The results of the
sensitivity analysis were consistent with our ﬁnding that
screening performance is not improved with the mixture
model method.
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The mixture model distributions in affected and unaffected
pregnancies and the standard MoM distributions are
similar (see Figure 1) so there is no reason to expect them
to yield materially different screening performances. In
both approaches, as gestational age (or CRL) increases
the distributions in Down’s syndrome and unaffected
pregnancies become closer; with the mixture model
method the unaffected distribution moves closer to the
almost stationary affected distribution while with the stan-
dard MoM method the affected distribution moves closer
to the stationary unaffected distribution. When both
methods were applied to an independent data-set, screening
performance was marginally better using the standard MoM
method with a single distribution, for example to achieve a
Figure 1 Mixture model distributions of nuchal translucency (NT) in mm and distributions of NT multiple of the median (MoM) values in Down’s
syndrome and unaffected pregnancies at 11, 12 and 13 completed weeks’ gestation. Truncation limits shown (vertical lines) are those speciﬁed by
Wright et al.
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12% using the mixture model and 10% using the standard
MoM method. The accuracy of risk estimation was margin-
ally better using the MoM approach, with estimated risks
calculated from the mixture model being lower than the
observed prevalence within each risk category. The sensi-
tivity analysis indicated that our results are robust to impre-
cision in estimating the distribution parameters of NT.
If it is known that the distributions of NT are different
in pregnancies with or without a factor other than Down’s
syndrome, then it is valid to construct a mixture model
with separate means and standard deviations for pregnan-
cies with and without such a factor among pregnancies
with and without Down’s syndrome. In the absence of
data on such an external factor the assumption of two
distributions based only on the distribution itself can be mis-
leading – tailoring a distribution too closely to the study
sample. It is unlikely to be generalizable to other data-sets.
If a distribution appears to have a ‘hump’ in one of its
tails, further research should be performed to explain the
reason for this and adopting a complex model avoided
unless it is shown to be necessary.
This study shows that the more complex mixture model
has no advantage over the standard MoM method in ante-
natal screening for Down’s syndrome.
...............
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APPENDIX A
Descriptionof themixturemodel
The mixture model method assumes that a variable, x, comes from two
(or more) sub-populations in affected individuals and two (or more)
in unaffected individuals. It is not possible to categorize the
sub-populations other than from the distribution of x. To illustrate
the method we consider a hypothetical marker x, and for simplicity
illustrate this in affected individuals only. Two distributions are ﬁtted
Table 2 NT and maternal age: observed prevalence of Down’s syndrome and median estimated risk in categories deﬁne by
quintiles of risk of Down’s syndrome in affected pregnancies
Mixture model method Standard MoM method
Risk
category
Number of
Down’s
syndrome
pregnancies
Median expected
risk of Down’s
syndrome
Prevalence
of Down’s
syndrome
Risk
category
Number of
Down’s
syndrome
pregnancies
Median expected
risk of Down’s
syndrome
Prevalence
of Down’s
syndrome
 1 in 2.9 21 1 in 1.9 1 in 1.6  1 in 1.0 21 1 in 1.0 1 in 1.7
1 in 2.9 21 1 in 12 1 in 6.4 1 in 1.0 21 1 in 3.1 1 in 6.8
1 in 26 21 1 in 70 1 in 20 1 in 9.2 21 1 in 32 1 in 17
1 in 111 21 1 in 223 1 in 97 1 in 58 21 1 in 184 1 in 90
 1 in 322 20 1 in 2249 1 in 988  1 in 308 20 1 in 2429 1 in 997
NT, nuchal translucency; MoM, multiple of the median
Table1 Screening performance of NTalone (measured between 11 and 13 weeks gestation), based on 104 Down’s syndrome
and 22,284 unaffected pregnancies according to method
DR (%) for FPR of FPR (%) for DR of
Method 1% 3% 5% 10% 50% 60% 70% 80% 90%
Mixture model method
1 41 57 62 68 1.9 4.3 12 28 43
Standard MoM method  42 56 63 68 1.7 4.1 10 20 41
NT, nuchal translucency; DR, detection rate; FPR, false-positive rate; MoM, multiple of the median
 Derived from the mixture model distributions
1
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observations belonging to one distribution and a proportion (p2)
belonging to the other. The resulting combined (mixed) distribution
is deﬁned by ﬁve parameters (2 means, 2 standard deviations and
p1 [not p2 since p2 ¼ 1 2 p1]). In practice with the inclusion of
unaffected individuals there would be 10 parameters.
Figure A1 shows two ﬁtted Gaussian distribution curves of a
hypothetical marker x in affected individuals (a), the mixture
distribution (b) and what might be observed to justify the use of a
mixture distribution, presented as a histogram (c). The ﬁve parameters
are estimated simultaneously and this could be performed using
maximum-likelihood estimation; the mixture distribution deﬁned by the
ﬁve parameters, which provides the best ﬁt to the data maximizes the
product of the likelihood (height of the curve) for each value of x.
Methods such as the expectation maximization algorithm can be used
to estimate the parameters or other methods, such as the Markov
Chain Monte Carlo procedure can be used.
After deﬁning a mixture distribution for a measurement in affected
and unaffected individuals, the risk of being affected is calculated in
the same way as with the standard single distribution method; that is
by multiplying the risk of being affected before having the
measurement (expressed as an odds) by the likelihood ratio
obtained from the mixture model distributions in affected and
unaffected individuals. As with the standard single distribution
method, the likelihood ratio for a value m of the screening marker is
the height of the affected mixture distribution curve (Figure A1(b) in
the hypothetical example above) at m divided by the height of the
unaffected mixture distribution curve at m. Calculating a weighted
average of the likelihood ratio from the CRL-dependent Gaussian
distribution and the likelihood ratio from the CRL-independent
Gaussian distribution using the proportion of pregnancies attributed
to each distribution as the weights would give an identical result.
APPENDIX B
Calculationof medianNT MoMinDown’s
syndrome pregnancies
Given the probability density function (pdf, equation of the curve) of a
Gaussian distribution is
fXðxÞ¼
1
ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s
exp  
(x   m)
2
2s2
 !
;
where m is the mean and s the standard deviation, then the pdf of a
mixture distribution is
fX1;X2ðx1;x2Þ¼
p1 ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s1
exp  
(x   m)
2
2s2
1
 !
þ
(1   p1)
ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s2
exp  
(x   m2)
2
2s2
2
 !
;
withp1theproportionofobservationsbelongingtoonedistributionand1
2 p1 the proportion belonging to the other distribution. The theoretical
median of a mixture distribution can be found by integrating the mixture
distribution between minus inﬁnity and m (or between m and inﬁnity).
The median can then be found by letting the integral equal to one-half
and solving for m, i.e. the median is calculated by ﬁnding the value of x
for which the area under the mixture distribution curve to the left and the
right of this value is equal to one-half. Formally this is written as
ð m
 1
p1 ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s1
exp  
(x   m1)
2
2s2
1
 !
þ
(1   p1)
ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s2
exp  
(x   m2)
2
2s2
2
 ! ()
dx
¼ 0:5:
This requires solving numerically since the solution to the integral is not
deﬁned. By using the above equations to ﬁnd the median NT in both
Down’s syndrome (mD) and unaffected pregnancies (mU), the median
MoM in Down’s syndrome pregnancies is calculated as mD/mU (by
deﬁnition the median MoM in unaffected pregnancies is equal to one).
Calculationofthestandard deviationof(log10)N T
MoMinDown’ssyndrome and unaffected
pregnancies
The overall standard deviation of the mixture of two Gaussian
distributions can be found by integrating the second moment of the
mixture distribution
m2 þ s2 ¼
ð1
 1
x2
(
p1 ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s1
exp  
(x   m)
2
2s2
1
 !
þ
(1   p1)
ﬃﬃﬃﬃﬃﬃﬃ
2p
p
s2
exp  
(x   m2)
2
2s2
2
 !)
dx;
where m ¼ p1m1 þ (1 2 p1)m2 is the overall mean (not to be confused
with the overall median) and s the overall standard deviation. This
does have a solution, so does not require approximation methods:
s ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p1m2
1 þ (1   p1)m2
2 þ p1s2
1 þ (1   p1)s2
2   m2
q
:
Inwordsthiscanbeexpressedasthesquarerootoftheweightedaverage
of the two squared means plus the weighted average of the two squared
standard deviations minus the overall mean squared. Standard
deviations calculated from the 2.5th to 97.5th centile interval would
produce estimates similar to those using the equation above. The means
and standard deviations of the mixture model method distributions and
standard MoM method distributions are shown in Table B1.
Figure A1 Two Gaussian distribution curves of hypothetical
screening marker x (a), mixture distribution curve (b) and histogram
of the marker that might be observed in affected individuals (c)
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Mixture model method (NT, mm)
Standard MoM method
(NT MoM)
Down’s syndrome Unaffected
Down’s
syndrome Unaffected Parameter CRL dependent CRL independent CRL dependent CRL independent
Median
11 completed weeks 1.29
)
3:41
1.29
)
2:00
2.50
)
1:00 12 completed weeks 1.70 1.70 1.92
13 completed weeks 1.96 1.96 1.67
Standard deviation (log10)
11 completed weeks
)
0:0841
)
0:2113
)
0:0841
)
0:1966
0.2289 0.1165
12 completed weeks 0.2180 0.0969
13 completed weeks 0.2136 0.0911
Proportion
11 completed weeks
)
0:0594
)
0:9406
0.8993 0.1007 – –
12 completed weeks 0.9359 0.0641 – –
13 completed weeks 0.9613 0.0387 – –
NT, nuchal translucency; CRL, crown–rump length; MoM, multiple of the median
18 Bestwick et al.
Journal of Medical Screening 2010 Volume 17 Number 1 www.jmedscreen.com